$6.08
0.16% today
Nasdaq, Apr 02, 09:16 pm CET
ISIN
US2290503075
Symbol
CYRX

CryoPort Stock price

$6.09
+1.30 27.01% 1M
-2.12 25.82% 6M
-1.69 21.72% YTD
-12.04 66.41% 1Y
-28.67 82.48% 3Y
-9.82 61.72% 5Y
-2.79 31.42% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
+0.01 0.16%
ISIN
US2290503075
Symbol
CYRX
Industry

Key metrics

Market capitalization $303.95m
Enterprise Value $327.18m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.43
P/S ratio (TTM) P/S ratio 1.33
P/B ratio (TTM) P/B ratio 0.83
Revenue growth (TTM) Revenue growth -2.09%
Revenue (TTM) Revenue $228.39m
EBIT (operating result TTM) EBIT $-66.36m
Free Cash Flow (TTM) Free Cash Flow $-33.58m
Cash position $261.75m
EPS (TTM) EPS $-2.49
P/E forward negative
P/S forward 1.24
EV/Sales forward 1.33
Short interest 5.36%
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

Buy
56%
Hold
44%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
228 228
2% 2%
100%
- Direct Costs 146 146
3% 3%
64%
82 82
1% 1%
36%
- Selling and Administrative Expenses 100 100
4% 4%
44%
- Research and Development Expense 18 18
2% 2%
8%
-36 -36
14% 14%
-16%
- Depreciation and Amortization 31 31
12% 12%
13%
EBIT (Operating Income) EBIT -66 -66
13% 13%
-29%
Net Profit -115 -115
15% 15%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Neutral
Seeking Alpha
2 days ago
Cryoport, Inc. (NASDAQ:CYRX ) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Tom Heinzen - Vice President, Corporate Development & Investor Relations Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer ...
Neutral
PRNewsWire
2 days ago
DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics.
Neutral
PRNewsWire
2 days ago
NASHVILLE, Tenn. , March 31, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced that the Company will host an investor call today, Monday, March 31, 2025, at 8:30 a.m.
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,186
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today